Tirzepatide has emerged as a groundbreaking treatment for type 2 diabetes, offering promising effects. However, the cost of this innovative drug and its access have become key topics for patients and healthcare practitioners. While tirzepatide has been approved by regulatory agencies, its expensive nature presents a significant challenge to many.